A detailed history of Ghost Tree Capital, LLC transactions in Corvus Pharmaceuticals, Inc. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 500,000 shares of CRVS stock, worth $4.09 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
500,000
Holding current value
$4.09 Million
% of portfolio
0.99%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.78 - $5.92 $890,000 - $2.96 Million
500,000 New
500,000 $2.64 Million

Others Institutions Holding CRVS

About Corvus Pharmaceuticals, Inc.


  • Ticker CRVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,553,500
  • Market Cap $381M
  • Description
  • Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...
More about CRVS
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.